Vendor Intelligence Report: Peptide Crafters
Published 12 Nov 2026. 35-page investigative report on who is behind Peptide Crafters: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.
Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.
Executive summary
Across 61 Finnrick lab tests, Peptide Crafters records 40 pass / 21 fail, for an overall pass rate of 66%. The brand average hides a split catalog: Semaglutide is the clearest strength, Retatrutide sits in the cautious current-lot-verification band, and CJC-1295 plus BPC-157 are weak enough to change vendor choice. The report also shows ratings contracting under stricter dose-weighted grading.
Beyond the vials, Peptide Crafters has a stronger U.S. operating trail than many anonymous storefronts, but not a clean public seller-of-record. An abandoned trademark application, Wyoming and Texas filings, Biocraft Innovations LLC, and Isotope Analytical LLC form the core record set. No public source reviewed names the person responsible for sourcing, QA review or batch release; that is an accountability gap, not proof that competent oversight is absent.
Channel authentication is the sharper buyer trap. The main site says PeptideCrafters.com is the only official site and shows card-payment recourse, while a brand-matching us.com storefront mirrors catalog and COA material but uses lower-recourse payment rails. The report also maps a formal affiliate program and referral-code ecosystem that can blur independent reviews, coupon pages and paid promotion.
Inside the full report:
- Per-product Finnrick pass/fail rates, rating trajectories and methodology-divergence charts for all 9 tested products.
- Corporate-record packet covering the USPTO file, Wyoming Biocraft filing and Texas Comptroller records for Biocraft and Isotope Analytical.
- Storefront-authentication analysis comparing PeptideCrafters.com with the us.com WooCommerce site, payment rails and hosted COA images.
- COA-program audit covering 636 reports across eight labs, verifier gaps, panel scope and missing heavy-metals/fentanyl screening.
- Affiliate-network analysis of GoAffPro, referral-code carriers, coupon sites and disclosure status.
Risk assessment
- CJC-1295 quality risk — high: CJC-1295 has 5 Finnrick tests, 1 pass / 4 fail and a 29.43% Finnrick rating.
- BPC-157 quality risk — high: BPC-157 has 11 Finnrick tests, 5 pass / 6 fail and a 48.14% Finnrick rating.
- TB-500 quality risk — medium: TB-500 has 6 Finnrick tests, 4 pass / 2 fail and a 46.81% Finnrick rating.
- Tesamorelin quality risk — medium: Tesamorelin has 3 Finnrick tests, 2 pass / 1 fail and a 50.57% Finnrick rating.
- Melanotan II dose-accuracy risk — medium: Melanotan II has 4 Finnrick tests, 2 pass / 2 fail, a 59.93% Finnrick rating and retained detail showing underfill history.
- Retatrutide, Tirzepatide and Ipamorelin current-lot variability risk — medium: Retatrutide is 9 tests, 7 pass / 2 fail, 78.57%; Tirzepatide is 6 tests, 4 pass / 2 fail, 76.24%; Ipamorelin is 7 tests, 5 pass / 2 fail, 68.32%.
- Brand/domain-confusion risk — high: The main site says PeptideCrafters.com is the only official website, while peptidecrafters.us.com mirrors the brand/catalog and offered PayPal, Zelle and Apple Cash with no card observed.
- Legal-entity and recourse transparency risk — medium: No Peptide Crafters LLC/Inc. or disclosed seller-of-record entity was found; Biocraft is the likely operator or fulfillment partner, but the direct legal link remains unresolved.
- Affiliate-promotion disclosure risk — medium: A live GoAffPro portal offers up to 10% commission, and the X/web scan found 21 referral-bearing entries with disclosure recorded as 1 yes / 19 no / 1 unclear.
- COA scope and lot-verification risk — medium: PeptidePrices found 636 reports, but also 27 listing cards backed only by endotoxin or microbial reports, public-verifier gaps and specific lot/strength discrepancies.